OERIS offers extended antiemetic coverage through a single injection that effectively prevents both acute and delayed CINV for up to five days
Medico Remedies receives order worth US$ 1,781,000
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The audit has been concluded with no major observations
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
